Forootan Mojgan, Repici Alessandro, Rajabnia Mohsen, Karimi Mohammad Ali, Jahanian Ali, Ketabi Moghadam Pardis, Mohammadi Mahsa, Ghadirzadeh Erfan, Soudi Abdorraoof, Paraandavaji Elham, Shafiei Sasan, Reza Zali Mohammad, Tashakoripour Mohammad
Gastroenterology and Liver Disease Research Center, Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran.
Humanitas University & Humanitas Research Hospital Milano Italy.
DEN Open. 2025 May 8;6(1):e70108. doi: 10.1002/deo2.70108. eCollection 2026 Apr.
To propose a novel first-line endoscopic therapy for treating polypoid lesions in solitary rectal ulcer syndrome (P-SRUS), the rarest and most challenging subtype of SRUS, which encompasses various endoscopic findings including mucosal erythema, superficial or deep ulcers, and polypoid lesions.
A prospective, single-arm study was conducted on 56 patients with histologically confirmed SRUS and broad-based polypoid lesions in the rectum and anal canal. These patients were referred to the Department of Motility Disorders of the Lower Gastrointestinal Tract. The lesions were removed using snare-assisted mucosal and fibrosis resection. Patients were monitored for clinical and endoscopic responses at 1, 3, 6, and 12 months post-treatment.
The study observed improvement in clinical symptoms, a complete endoscopic response, and the absence of late complications following endoscopic resection. Endoscopic evaluations revealed no recurrence of lesions in the follow-up period.
Endoscopic resection using the snare-assisted mucosal and fibrosis resection method appears to be an effective and safe treatment option for polypoid SRUS. (Clinical Trial Registration Number: IRCT20211101052935N2).
提出一种新型一线内镜治疗方法,用于治疗孤立性直肠溃疡综合征(P-SRUS)中的息肉样病变,P-SRUS是SRUS最罕见且最具挑战性的亚型,其包括多种内镜检查结果,如黏膜红斑、浅表或深部溃疡以及息肉样病变。
对56例经组织学确诊为SRUS且直肠和肛管有广基息肉样病变的患者进行了一项前瞻性单臂研究。这些患者被转诊至下消化道动力障碍科。采用圈套辅助黏膜及纤维化切除术切除病变。在治疗后1、3、6和12个月对患者进行临床和内镜反应监测。
该研究观察到临床症状改善、内镜完全缓解且内镜切除后无晚期并发症发生。内镜评估显示随访期间病变无复发。
采用圈套辅助黏膜及纤维化切除术的内镜切除术似乎是息肉样SRUS的一种有效且安全的治疗选择。(临床试验注册号:IRCT20211101052935N2)